A single high-profile statement can reshape how millions think about their health
When a sitting president invoked the language of medical certainty to link a common painkiller to autism and endorse an unproven treatment, millions of people responded not with skepticism but with search bars and shopping intent. The announcement, made at the White House in September 2025, generated search surges that dwarfed what evidence warranted — a reminder that authority and truth are not the same thing, and that the distance between a podium and a pharmacy can be shorter than science would wish. Researchers documenting the aftermath found not merely curiosity in the data, but the fingerprints of behavior change: fewer pregnant women reaching for paracetamol, more children being prescribed leucovorin. The study measures no harm directly, but it maps the terrain where harm becomes possible.
- A single White House press conference in September 2025 sent leucovorin searches soaring 378.7% above predicted levels — nearly 1.2 million additional queries in two weeks — despite no credible scientific basis for the endorsement.
- Paracetamol searches exploded 186.8% overall, but the most alarming spike came from pregnant women: queries combining paracetamol, autism, and pregnancy jumped 1,322.4%, suggesting fear had taken hold in one of medicine's most vulnerable populations.
- Purchase-intent searches for leucovorin and related compounds surged over 200%, signalling that millions were not merely curious — they were actively trying to obtain drugs their doctors had not recommended.
- Separate research cited by the authors indicates the searches translated into real-world shifts: reduced paracetamol use among pregnant women and increased leucovorin prescribing for children, changes driven by a statement the scientific community had already discredited.
- The study's authors issued a quiet but pointed call to clinicians and health leaders: high-profile announcements reshape patient behaviour whether or not the evidence supports them, and that gap between authority and accuracy carries genuine risk.
In September 2025, President Trump announced from the White House that paracetamol — the everyday painkiller — was linked to autism when taken during pregnancy, and that leucovorin, a generic folinic acid formulation, could treat autism itself. Scientists moved quickly to push back, publishing reviews that debunked the paracetamol connection and cautioned that leucovorin evidence remained far too preliminary for such a recommendation. But the public had already heard the claim.
Researchers monitoring Google search patterns found the announcement had triggered surges bearing almost no relationship to the actual evidence. Leucovorin searches jumped 378.7% above forecast levels — roughly 1.19 million additional queries. Folinic acid and folate searches added another 561,000. Multivitamins, used as a control, did not move at all.
The paracetamol response was even larger. General searches for the drug climbed 186.8%, generating nearly 11.7 million searches beyond baseline predictions. Searches combining paracetamol with autism and pregnancy surged 1,322.4% — an estimated 4.37 million additional queries — suggesting that pregnant women in particular were alarmed. Purchase-intent searches for leucovorin and related compounds rose over 200%, indicating people were not merely reading but actively trying to buy.
Publishing in JAMA Network Open, the researchers were careful to note they had measured search behaviour, not medication use. But they pointed to separate findings suggesting real-world consequences had followed: pregnant women appeared to be reducing paracetamol use, and leucovorin prescribing for children had increased. Whether those changes caused harm or benefit remained unmeasured.
The authors called on clinicians and health leaders to reckon with what the data revealed — that a single confident statement from a figure of authority, even one later contradicted by science, can rapidly reshape how millions of people manage their health. The study does not assign blame so much as illuminate a structural vulnerability: the gap between evidence and public belief can widen in an instant, and it widens fastest when power speaks with the voice of certainty.
In September 2025, President Trump stood before White House cameras and made a claim that would ripple through the internet for months to come: that acetaminophen—the common painkiller known as paracetamol outside the US—was linked to autism when taken during pregnancy. He also endorsed leucovorin, a generic folinic acid formulation, as a treatment for autism itself. The scientific community quickly pushed back. Reviews emerged debunking the paracetamol connection and cautioning that evidence for leucovorin remained too preliminary to support such a recommendation. But the damage, in terms of public attention, had already been done.
Researchers tracking Google search patterns found something striking: the announcement had triggered a surge in health-related queries that bore little relationship to the actual state of the evidence. Using Google Trends data, they compared search volumes in the two weeks after the press conference against what forecasting models predicted would happen based on pre-announcement patterns. The disparities were enormous. Searches for leucovorin alone jumped 378.7 percent above expected levels—roughly 1.19 million additional searches. Folinic acid and folate queries rose 53.2 percent, adding another 561,456 searches to the baseline. Multivitamins, used as a control group, showed no change whatsoever.
The paracetamol response dwarfed even these numbers. General searches for the drug climbed 186.8 percent, translating to nearly 11.7 million searches beyond what models predicted. But the most dramatic spike came when researchers looked at searches combining paracetamol with autism and pregnancy—those queries jumped 1,322.4 percent, generating an estimated 4.37 million additional searches. Ibuprofen saw a smaller uptick, possibly reflecting consumers hunting for alternative pain relievers or simply confused about which medications were being discussed. Diphenhydramine, another control drug, remained stable.
What made these numbers particularly concerning was that they appeared to reflect not just curiosity but intent to purchase. Searches indicating buying interest in leucovorin, folinic acid, or folate surged 202.7 percent, representing roughly 80,872 additional transactions-oriented queries. Purchasing-related searches for multivitamins did not budge. The data suggested that people were not merely reading about these drugs—they were actively looking to obtain them.
The researchers, publishing their findings in JAMA Network Open, were careful to note that their study measured search behavior, not actual medication use. But they cited separate research suggesting the searches had translated into real-world changes: decreased paracetamol use among pregnant women and increased leucovorin prescribing for children in the weeks following the announcement. The implication was sobering. A single high-profile statement, even one later discredited by the scientific establishment, had the power to reshape how millions of people thought about their health and their medications.
The authors called for reflection among health leaders and clinicians. "Health leaders could consider how endorsements and warnings about medical products based on limited evidence may influence patients' health decisions," they wrote, "and health care professionals could consider the influence of high-profile announcements on consumer health behaviour when counselling patients." The study did not measure whether these search-driven changes caused harm—whether pregnant women who stopped taking paracetamol suffered worse outcomes, or whether children given leucovorin experienced benefit or risk. But it made clear that the gap between what evidence supports and what the public believes can be vast, and that gap can widen very quickly when authority figures speak with confidence about medical matters they may not fully understand.
Notable Quotes
Health leaders could consider how endorsements and warnings about medical products based on limited evidence may influence patients' health decisions.— JAMA Network Open study authors
The Hearth Conversation Another angle on the story
Why does a search spike matter if people don't actually change their behavior?
The researchers found evidence they did change behavior—paracetamol use dropped among pregnant women, leucovorin prescriptions went up for kids. A search is often the first step before a decision.
But the announcement was debunked. Didn't that matter?
It did matter scientifically. But by then millions of people had already searched, read, worried, and some had already acted. The debunking came after the momentum had started.
What's the actual risk here? Is paracetamol dangerous in pregnancy?
The evidence doesn't support that claim. But if pregnant women stopped taking it because they were frightened, they might suffer worse pain or fever without treatment—which has its own risks.
So the harm isn't from the drug itself but from the fear?
Partly. And from people taking leucovorin without medical guidance, or instead of proven treatments. The study didn't measure health outcomes, only behavior. We don't know yet what actually happened to people.
Why is this a political story and not just a medical one?
Because it came from the White House, from the President himself. That's why it moved so many people. A doctor saying the same thing in a journal would reach thousands. Trump saying it reached millions.